Formulation: A 5 mg/ml solution in ethanol

Purity: ≥95%

• 1-Hexadecanoyl-2-glutaroyl-sn-glycero-3-phosphocholine
• 1-Palmitoyl-2-glutaryl phosphatidylcholine
• 1-Palmitoyl-2-glutaryl-sn-glycero-3-phosphocholine

Formulation: A crystalline solid

Purity: ≥98%

• 1,2-Dimyristoyl-sn-glycero-3-phospho-(1'-rac-glycerol)
• 1,2-DMPG

Formulation: A crystalline solid

Purity: ≥98%

• 1,​2-​Distearoyl-​rac-​glycero-​3-​phospho-​(1'-​rac-​glycerol)
• 1,2-Distearoyl-rac-glycero-3-phosphoglycerol
• 1,2-DSPG

Formulation: A crystalline solid

Purity: ≥98%

• 1,2-Dihexadecanoyl-sn-glycero-3-phosphatidylglycerol
• 1,2-Dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol)
• 1,2-Dihexadecanoyl-sn-glycero-3-phosphoglycerol
• 1,2-DPPG
• MG 6060LS
• 16:0/16:0-PG
• PG(16:0/16:0)

Formulation: A crystalline solid

Purity: ≥95% (9:1 mixture of 1-acyl and 2-acyl)

• 14:0 Lyso-PG
• 1-Myristoyl-2-hydroxy-sn-glycero-3-phosphoglycerol
• 1-Myristoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol)

Formulation: A crystalline solid

Purity: ≥98%

• 1-Palmitoyl-2-Oleoyl-sn-glycero-3-phosphoglycerol
• 1-Palmitoyl-2-Oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol)
• PG(16:0/18:1(9Z))
• 1,2-POPG

Formulation: A crystalline solid

Purity: ≥95%

• 1,2-Dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol)
• 1,2-Dioleoyl-sn-glycero-3-phosphoglycerol
• 1,2-DOPG
• 18:1 (Δ⁹-cis) PG

Formulation: A crystalline solid

Purity: ≥95%

• 1,2-Dilauroyl-sn-glycero-3-phospho-sn-glycerol
• 1,2-DLPG

Formulation: A crystalline solid

Purity: ≥95%

• 16:0 Lyso-PG
• 1-Palmitoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol)
• 1-Palmitoyl-2-hydroxy-sn-glycero-3-phosphoglycerol

Formulation: A crystalline solid

Purity: ≥95% (9:1 mixture of 1-acyl and 2-acyl)

• 18:0 Lyso-PG​
• 1-Stearoyl-2-hydroxy-sn-glycero-3-phosphoglycerol
• 1-Stearoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol)

Formulation: A 1 mg/ml solution in chloroform

Purity: ≥99% deuterated forms (d₁-d₉)

• 1-Hexanoyl-d₉-2-hexanoyl-sn-glycero-3-phosphatidylglycerol
• 1-Hexanoyl-d₉-2-hexanoyl-sn-glycero-3-phosphoglycerol
• 1-Palmitoyl-d₉-2-Palmitoyl-sn-glycero-3-phosphatidylglycerol
• 1-Palmitoyl-d₉-2-Palmitoyl-sn-glycero-3-phosphoglycerol
• 16:0-d₉/16:0-PG
• PG(16:0-d₉/16:0)

Formulation: A 10 mg/ml solution in chloroform

Purity: ≥95% (9:1 mixture of 1-acyl and 2-acyl)

• 18:1 Lyso-PG
• 1-Oleoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol)
• 1-Oleoyl-2-hydroxy-sn-glycero-3-phosphoglycerol

Formulation: A 5 mg/ml solution in ethanol

Purity: ≥99% deuterated forms (d₁-d₆)

• 1-Palmitoyl-2-glutaryl Phosphatidylcholine-d₆

Formulation: A crystalline solid

Purity: ≥95%

• 1,2-bis(heptanoylthio) Glycerophosphatidylglycerol
• 1,2-bis(heptanoylthio) Glycerophosphoglycerol
• Diheptanoyl Thio-PG

Formulation: A solid

Purity: ≥95%

• 1,2-Ditetradecanoyl-sn-glycero-3-Phosphoethanolamine-PGA-diol40
• 1,2-Dimyristoyl-sn-glycero-3-Phosphoethanolamine-PGA-diol40
• 1,2-Dimyristoyl-sn-glycero-3-Phosphoethanolamine-poly[L-glutamic acid-(3-aminopropane-1,2-diol)]40
• 1,2-DMPE-PGA-diol40
• PE(14:0/14:0)-PGA-diol₄₀
• PtdEtn-(1,2-Dimyristoyl)-PGA-diol40

Formulation: A 5 mg/ml solution in methanol

Purity: ≥95% (9:1 mixture mixture of 1', 2' acyl chain isomers))

• 1-Hexadecanoyl-2-(9(Z)12(Z)-octadecadienoyl)-sn-glycero-3-phosphoglycerol
• 1-Palmitoyl-2-linoleoyl Phosphatidylglycerol
• PG(16:0/18:2)
• PG(16:0/18:2(9Z,12Z))
• 1,2-PLPG
• PtdGly-(1-palmitoyl, 2-linoleoyl)

Formulation: A solid

Purity: ≥98%

• 1,2-Didodecanoyl-sn-glycero-3-phospho-(2R)-glycerol
• 1,2-Dilauroyl-sn-glycero-3-phosphorylglycerol
• DLPG
• PG(12:0/12:0)

Formulation: A solution in chloroform

Purity: ≥98%

• E 322
• Lecithin (bovine)
• Lecithinon
• Phospholutein
• PtdCho
• 3-fluoro UB

Formulation: A solution in chloroform

Purity: ≥98%

• E 322
• Lecithin (egg)
• Lecithinon
• Phospholutein
• PtdCho
• 3-fluoro UB

Formulation: A solid

Purity: ≥98%

• PGs (egg)
• L-α-Phosphatidylglycerols (egg)

Formulation: A 10 mg/ml solution in ethanol

Purity: ≥97%

Formulation: 200 µg or 1 mg of DSPE-PEG(2000)-MACTIDE click conjugate

• 1,2-Distearoyl Phosphatidylethanolamine-PEG(2000)-MACTIDE
• 1,2-DSPE-PEG(2000)-CD206 Cyclic Peptide Ligand
• DSPE-PEG(2000)-triazole-F-Ahx-G(CTKSIPPIC)SPGAK
• DSPE-PEG(2000)-UNO-related Cyclic Peptide

Formulation: A 250 µg/ml solution in ethanol

Purity: ≥99% deuterated forms (d₁-d₉)

• 1-Hexadecanoyl-d₉-2-hydroxy-sn-glycero-3-phosphate
• 16:0-d₉ LPA
• LPA 16:0-d₉
• PA(16:0-d₉/0:0)
• 1-Palmitoyl-d₉ LPA
• 1-Palmitoyl-d₉ Lysophosphatidic Acid

Formulation: A 1 mg/ml solution in ethanol

Purity: ≥99% deuterated forms (d₁-d₄)

Formulation: A 5 mg/ml solution in ethanol

Purity: ≥95%

• C16(plasm)-18:2-PC
• ​1-1(Z)-Hexadecenyl-2-Linoleoyl-sn-glycero-3-PC
• 1-1(Z)-Hexadecenyl-2-(9Z,12Z)-Octadecadienoyl-sn-glycero-3-Phosphocholine
• 16:0p/18:2-PC
• PC(P-16:0/18:2)
• PlgPC 16:0/18:2